Thank you Trding , just why 70% , I though with longer overlap FDA consider 525 mg at 95% efficacy , witch is great, I believe those patients were with 3 weeks overlap , now they be doing 4 weeks...
But I was almost sure they want to go with Receptor Occupancy Test ,
Little confusing here... I guess we should know after shareholder meeting ..
Thank you.